Cyxone appoints Cornel Pater as new Chief Medical Officer
Cyxone today announced that Cornel Pater has been appointed as the company’s new Chief Medical Officer (CMO). Most recently, he held the position as Global Medical Director of Clinical Development at Novartis Pharma. As CMO, Cornel Pater is part of Cyxone’s executive management and will play an important role in the continued development of the company’s projects. He joined the company on August 31, 2021.“I am glad to welcome Cornel Pater to Cyxone. As Chief Medical Officer, his comprehensive knowledge and experience from leading pharmaceutical development projects and coordinating global